Connect Sign In
0098727
Alpha-2-Antiplasmin, Activity
ALPHA 2A
Ordering Recommendation
Use to screen for alpha-2-antiplasmin deficiency. Not a first-line test for diagnosing inherited thrombotic or bleeding disorders.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.
Specimen Preparation
Transfer 1 mL platelet-poor plasma to an ARUP standard transport tube. (Min: 0.5 mL)
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Unacceptable Conditions
Serum. EDTA plasma, clotted or hemolyzed specimens.
Remarks
Stability
mbient: 4 hours; Refrigerated: Unacceptable; Frozen: at -20° C: 3 months; at -70° C: 6 months
Methodology
Chromogenic Assay
Performed
Thu
Reported
1-8 days
Reference Interval
By Report
| Age | Activity (%) |
| 1-4 days | 55-115% |
| 5-29 days | 70-130% |
| 30-89 | 76-124% |
| 90-179 days | 76-140% |
| 180-364 days | 83-139% |
| 1-5 years | 93-117% |
| 6 years | 89-110% |
| 7-9 years | 88-147% |
| 10-11 years | 90-144% |
| 12-13 years | 87-142% |
| 14-15 years | 83-136% |
| 16-17 years | 77-134% |
| 18 years and older | 82-133% |
Interpretive Data
Compliance Category
FDA
Note
Hotline History
N/A
CPT Codes
85410
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0098727 | Alpha-2 Antiplasmin Activity | 27810-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- a2-Antiplasmin
- Alpha 2 Antiplasmin
- Alpha-2 Proteinase Inhibitor
- Antiplasmin, Activity, Plasma
- Antiplasmin, Functional, Plasma
- Functional Antiplasmin
- Plasmin Inhibitor
Alpha-2-Antiplasmin, Activity
